These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 28012492)

  • 1. Guidelines-concordant empiric antimicrobial therapy and mortality in patients with severe community-acquired pneumonia requiring mechanical ventilation.
    Sakamoto Y; Yamauchi Y; Yasunaga H; Takeshima H; Hasegawa W; Jo T; Matsui H; Fushimi K; Nagase T
    Respir Investig; 2017 Jan; 55(1):39-44. PubMed ID: 28012492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia.
    Mortensen EM; Restrepo MI; Anzueto A; Pugh J
    Crit Care; 2005 Dec; 10(1):R8. PubMed ID: 16420641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort.
    Ito A; Ishida T; Tokumasu H; Washio Y; Yamazaki A; Ito Y; Tachibana H
    BMC Pulm Med; 2017 May; 17(1):78. PubMed ID: 28464807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia.
    Mortensen EM; Restrepo M; Anzueto A; Pugh J
    Am J Med; 2004 Nov; 117(10):726-31. PubMed ID: 15541321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to guidelines and its impact on outcomes in patients hospitalized with community-acquired pneumonia at a university hospital.
    Silveira CD; Ferreira CS; Corrêa Rde A
    J Bras Pneumol; 2012; 38(2):148-57. PubMed ID: 22576421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis factors and outcome of community-acquired pneumonia needing mechanical ventilation.
    Tejerina E; Frutos-Vivar F; Restrepo MI; Anzueto A; Palizas F; González M; Apezteguía C; Abroug F; Matamis D; Bugedo G; Esteban A;
    J Crit Care; 2005 Sep; 20(3):230-8. PubMed ID: 16253791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia.
    Grenier C; Pépin J; Nault V; Howson J; Fournier X; Poirier MS; Cabana J; Craig C; Beaudoin M; Valiquette L
    J Antimicrob Chemother; 2011 Jul; 66(7):1617-24. PubMed ID: 21586592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.
    Reyes Calzada S; Martínez Tomas R; Cremades Romero MJ; Martínez Moragón E; Soler Cataluña JJ; Menéndez Villanueva R
    Respir Med; 2007 Sep; 101(9):1909-15. PubMed ID: 17628462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin plus β-lactam versus levofloxacin plus β-lactam for severe community-acquired pneumonia: A retrospective nationwide database analysis.
    Suzuki J; Sasabuchi Y; Hatakeyama S; Matsui H; Sasahara T; Morisawa Y; Yamada T; Yasunaga H
    J Infect Chemother; 2019 Dec; 25(12):1012-1018. PubMed ID: 31227381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial Resistance and Clinical Outcomes in Nursing Home-Acquired Pneumonia, Compared to Community-Acquired Pneumonia.
    Kang YS; Ryoo SR; Byun SJ; Jeong YJ; Oh JY; Yoon YS
    Yonsei Med J; 2017 Jan; 58(1):180-186. PubMed ID: 27873512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia.
    Rello J; Rodriguez A; Torres A; Roig J; Sole-Violan J; Garnacho-Montero J; de la Torre MV; Sirvent JM; Bodi M
    Eur Respir J; 2006 Jun; 27(6):1210-6. PubMed ID: 16510452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penicillin treatment for patients with Community-Acquired Pneumonia in Denmark: a retrospective cohort study.
    Egelund GB; Jensen AV; Andersen SB; Petersen PT; Lindhardt BØ; von Plessen C; Rohde G; Ravn P
    BMC Pulm Med; 2017 Apr; 17(1):66. PubMed ID: 28427381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of prognostic factors in hospitalized patients with pneumonia occurring outside hospital: Serum albumin is not less important than pneumonia severity assessment scale.
    Miyazaki H; Nagata N; Akagi T; Takeda S; Harada T; Ushijima S; Aoyama T; Yoshida Y; Yatsugi H; Fujita M; Watanabe K
    J Infect Chemother; 2018 Aug; 24(8):602-609. PubMed ID: 29628384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia.
    Arnold FW; Lopardo G; Wiemken TL; Kelley R; Peyrani P; Mattingly WA; Feldman C; Gnoni M; Maurici R; Ramirez JA;
    Respir Med; 2018 Jul; 140():115-121. PubMed ID: 29957272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home.
    Chen JI; Slater LN; Kurdgelashvili G; Husain KO; Gentry CA
    Ann Pharmacother; 2013 Jan; 47(1):9-19. PubMed ID: 23324506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of guideline-concordant microbiological testing on outcomes of pneumonia.
    Uematsu H; Hashimoto H; Iwamoto T; Horiguchi H; Yasunaga H
    Int J Qual Health Care; 2014 Feb; 26(1):100-7. PubMed ID: 24257160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-acquired pneumonia.
    Cassiere HA; Niederman MS
    Dis Mon; 1998 Nov; 44(11):613-75. PubMed ID: 9858958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality differences among hospitalized patients with community-acquired pneumonia in three world regions: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study.
    Arnold FW; Wiemken TL; Peyrani P; Ramirez JA; Brock GN;
    Respir Med; 2013 Jul; 107(7):1101-11. PubMed ID: 23660396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health care-associated pneumonia in the intensive care unit: Guideline-concordant antibiotics and outcomes.
    Attridge RT; Frei CR; Pugh MJ; Lawson KA; Ryan L; Anzueto A; Metersky ML; Restrepo MI; Mortensen EM
    J Crit Care; 2016 Dec; 36():265-271. PubMed ID: 27595461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.